why choose us

First received: November 09, 2022

Clinical Trial: [18F]MC225-PET in Neurodegenerative Disease

Study Status: Completed

Recruit Status: RECRUITING

Condition: Neurodegenerative Diseases

Study Type: INTERVENTIONAL


Official Title: Evaluation of [18F]MC225-PET to Measure P-glycoprotein Function in Neurodegenerative Disease

Brief Summary: P-glycoprotein, an efflux transporter at the blood-brain barrier plays an important role in de development of neurodegenerative disease.A novel PET tracer ([18F]MC225) was developed to measure the function of P-glycoprotein and was tested with succes in healthy volunteers.This study aims to evaluate [18F]MC225 in neurodegenerative disease.

Read more